Vilnius University Hospital Santaros Klinikos in Vilnius, Lithuania is a teaching hospital of the Vilnius University Faculty of Medicine. Santaros Klinikos is co-funded by the Lithuanian Ministry of Health and Vilnius University.

During the past decade, Vilnius University Hospital conducted 33 clinical trials. In the 10-year time frame, 33 clinical trials started and 16 clinical trials were completed, i.e. on average, 48.5% percent of trials that started reached the finish line to date. In the past 5 years, 16 clinical trials started and 12 clinical trials were completed. i.e. 75% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Vilnius University Hospital" #1 sponsor was "Amgen" with 4 trials, followed by "Janssen Research & Development, LLC" with 4 trials sponsored, "Takeda" with 4 trials sponsored, "Anergis" with 3 trials sponsored and "Baxalta now part of Shire" with 3 trials sponsored. Other sponsors include 18 different institutions and companies that sponsored additional 25 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Vilnius University Hospital" #1 collaborator was "OCT Clinical Trials" with 2 trials as a collaborator, "Quintiles, Inc." with 2 trials as a collaborator, "Advanced Accelerator Applications" with 1 trials as a collaborator, "Arena is a wholly owned subsidiary of Pfizer" with 1 trials as a collaborator and "Baxalta Innovations GmbH, now part of Shire" with 1 trials as a collaborator. Other collaborators include 18 different institutions and companies that were collaborators in the rest 28 trials.

According to Clinical.Site data, the most researched conditions in "Vilnius University Hospital" are "Crohn's Disease" (4 trials), "Ulcerative Colitis" (4 trials), "Atrial Fibrillation" (3 trials), "Colitis, Ulcerative" (3 trials) and "Hemophilia A" (3 trials). Many other conditions were trialed in "Vilnius University Hospital" in a lesser frequency.

Most popular intervention types in "Vilnius University Hospital" are "Drug" (27 trials), "Biological" (5 trials), "Other" (5 trials), "Device" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (12 trials), "Etrasimod" (3 trials), "Dexamethasone" (2 trials), "Guselkumab" (2 trials) and "Guselkumab Dose 1" (2 trials). Other intervention names were less common.

The vast majority of trials in "Vilnius University Hospital" are 38 trials for "All" genders and 3 trials for "Male" genders.

Currently, there are NaN active trials in "Vilnius University Hospital". undefined are not yet recruiting, 12 are recruiting, 5 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 23 completed trials in Vilnius University Hospital, undefined suspended trials, and 1 terminated clinical trials to date.

Out of the total trials that were conducted in Vilnius University Hospital, 0 "Phase 1" clinical trials were conducted, 8 "Phase 2" clinical trials and 25 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 1 trials, and there were also 4 trials that are defined as “Not Applicable".